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pared with nontumorigenic cells of the same lineage (4, 15, 28, 31) . In vivo,elevated plasma polyamine levels are associated with malignancy and tissue wasting, and tumor cells acquire polyamines released into the circulation (28) . Selective inhibition of ODC with inhibitors such as 2-(difluoromethyl)-ornithine results in a compensatory increase in polyamine transport (4) . Such upregulation of polyamine transport substitutes for de novo polyamine biosynthesis [for a review, see Ref. 50] . It is for these reasons that inhibition of ODC or the polyamineconverting enzymes alone have often complicated in vivo experimental interpretations as to the importance of polyamines and yielded less than anticipated results in clinical trials (17, 25, 28, 38, 45, 48) . The importance of polyamine transport in addition to biosynthesis in affecting intracellular polyamine levels is now well established [for a review, see (49) ]. Thus, beneficial intervention must be concerned with polyamine transport as well as biosynthesis when addressing intracellular polyamine availability for growth.
Intracellular polyamine levels are autoregulated via induction of the regulatory protein ODC antizyme (23) . Induction of antizyme is via a programmed ϩ1 ribosomal frameshift (23) . This novel mechanism of translational induction affords rapid modulation in response to increased intracellular polyamine concentrations. As such, the cell is required to maintain constitutive levels of antizyme mRNA requisite for this response, which underscores the importance of this system in normal cell homeostasis. Four isoforms of antizyme have been described (22) . Here, we refer to the most abundant, ubiquitous isoform, ODC antizyme-1. Antizyme binds to ODC, inhibits its activity and accelerates its degradation in a process catalyzed by the 26S proteasome (7, 13, 29) . In addition to inhibiting polyamine biosynthesis, antizyme concurrently suppresses polyamine transporter activity (26, 51) . This unique two-pronged negative feedback system is effective in limiting intracellular polyamine concentrations.
Arginine decarboxylase (ADC) converts arginine to agmatine. Intracellular concentrations of agmatine vary among organs, with high levels of synthesis and expression in kidney and liver (19, 20, 27) . Agmatine inhibits proliferation by suppressing intracellular polyamine levels (1, 9, 42, 53) . It induces antizyme expression via a programmed ϩ1 ribosomal frameshift and is the only known endogenous molecule, other than the canonical polyamines, with this capacity (14, 42) .
Agmatine induces spermidine/spermine acetyltransferase in some cells types, which would promote the back-conversion of higher-order, more highly charged, to lower-order polyamines (53) . It may also induce a yet unknown mechanism of suppressing ODC activity independent of antizyme (1). All of these mechanisms reduce intracellular polyamine pools and suppress growth.
We and others have shown that agmatine enters mammalian cells via the polyamine transporter (1, 3, 6, 40) . As polyamine transport is positively correlated with proliferation rate, we examined whether agmatine preferentially targets rapidly proliferating, transformed cells (41) . In this report, we investigate the effects of agmatine on primary, immortalized, transformed and tumorigenic cell lines and demonstrate that the antiproliferative effects correlate with the rate of proliferation in these cell lines. Transport experiments. Monitoring intracellular transport was performed as previously described (39) . Briefly, cells were grown in 6-well culture plates for 3 days until near confluence. Twenty-four hours before the uptake experiments, cells were placed in medium with limited (0.1%) FBS. Wells were washed with HEPES buffer (in mM): 25 Na ϩ -free HEPES, 5 KCl, 0.9 CaCl2, 1 MgSO4, 5.6 D-glucose, 137 NaCl. The addition of HEPES buffer containing 10 M [ 3 H]agmatine at ϳ200,000 cpm/well started the 30-min uptake period. Three rapid washes with ice-cold PBS and lysis in 3N NaOH terminated the reactions. Bio-Rad Protein Assay (Bio-Rad, Hercules, CA) used a small aliquot of each lysate for protein determination; the remainder of the sample was counted in a ␤-scintillation counter to evaluate uptake. Uptake at 4°C, representing nonspecific binding and diffusional transport, was subtracted from the above determinations.
MATERIALS AND METHODS

Materials
Intracellular agmatine determination. Cells were plated on 10-cm culture dishes. Twenty-four hours before extraction, the cells were placed in serum-free medium, except the primary fibroblast cell line, which required 0.1% FBS. Eight hours after medium change, 100 M agmatine was added to the experimental samples for a 16-h uptake period at 37°C. Cells were then washed with ice-cold PBS and lysed in 10% TCA in 10 mM HCl. The sample supernatants were transferred to a 10,000 molecular weight spin filter (Millipore) for further purification, and then they were extracted three times with hydrated ethyl ether to remove traces of TCA and lipids. Cell extracts and standards were derivatized for fluorescence detection of primary and secondary amine groups with N-hydroxysuccinimidyl-6-aminoquinoyl carbamate as per kit instructions (AccQ tag; Waters, Franklin, MA). Elution was performed using a Hewlett-Packard 1100 series binary HPLC pump system with a 250-mm 3-m ODS Hypersil C18 RP column (Hewlett-Packard) maintained at 45°C. Fluorescence was detected in line using a Waters 470 detector linked to the data acquisition system. Elution gradients were based on the AccQ tag kit instructions.
Cell counting. Cells were plated for the days indicated in 10-cm culture dishes or 6-well plates, washed with PBS, and harvested in trypsin/EDTA for quantification in a Coulter Counter (model ZM). In experiments in which cells were preloaded with putrescine, 250 M putrescine was added to the cells 3 h before the addition of agmatine. Polyamine transport inhibitors MQT1202 (1 M) and MQT1483 (1 M) were also added 3 h before agmatine administration.
Western blot analysis. For Western blot analysis, Ras/3T3 cells were collected and lysed [lysis buffer: 1% triton-X 100, 0.5% deoxycholic acid, 1 mM EDTA, 0.1% SDS, 4 mM NaF, Complete protease cocktail (Roche Molecular Biochemicals, Mannheim, Germany), 0.7 g/ml pepstatin and 1 mM NaVO4 in PBS]. Lysates were resolved on 12% NuPAGE gels in MOPS buffer (Invitrogen, Carlsbad, CA). Gel proteins were transferred to nitrocellulose membranes and immunoblotted with antizyme-1 antibody (24). This antibody cross-reacts weakly with mouse antizyme-2 (data not shown). The secondary antibody was horseradish peroxidase-conjugated (Santa Cruz Biotechnology, Santa Cruz, CA) for autoradiographic detection by ECL Plus (Amersham Pharmacia, Piscataway, NJ), with densitometric analysis by ImageJ Software (National Institutes of Health, Bethesda, MD).
Determination of antizyme activity. The cells were washed with ice-cold PBS and disrupted by three freeze-thaw cycles. Then, 0.5 ml of extract buffer (25 mM Tris ⅐ HCl, pH 7.4, 1 mM DTT, and 0.01% Tween 80) was added, and the cell suspension was centrifuged at 18,000 g for 20 min at 4°C. The supernatant contained both active free ODC and inactive ODC bound to antizyme (ODC-antizyme complex). Free ODC activity was assayed by measuring the release of 14 CO2 from L- [1- 14 C] ornithine. The basal reaction mixture contained 0.0625 mCi of L- [1- 14 C ]ornithine, 0.4 mM L-ornithine, 40 mM pyridoxal phosphate, 5 mM DTT, 40 mM Tris ⅐ HCl buffer, pH 7.4, 0.01% Tween 80 and enzyme solution in a final volume of 125 ml. Inactive ODC (ODC-antizyme complex) was determined as the increase in ODC activity caused by the addition of an excess amount of recombinant GST fusion antizyme inhibitor (0.1 mg) to the basal reaction mixture described above. Antizyme activity was equated to the amount of ODC-antizyme complex.
Statistical evaluations. Variations between samples within groups were analyzed by ANOVA, with significance determined by Fisher's protected least significant differences post hoc test. StatView software (ver. 4.5; Abacus Concepts, Berkeley, CA) was used for these analyses. All data are means (SD) and represent at least three separate determinations.
RESULTS
Transport and accumulation of agmatine in cell lines.
An increased rate of cellular proliferation is associated with increased polyamine uptake. We and others have shown that agmatine import into mammalian cells uses the polyamine transport system (1, 6, 40, 41) . Although epithelial cells are primarily chosen for proliferation studies because of their prevalence in cancer, plasticity in epithelial tumor cells toward a fibroblastoid phenotype in progression toward metastasis, that is, an epithelial-mesenchymal transition, is now well established (12) . Furthermore, polyamine transport is well characterized in fibroblast cell lines and display a single polyamine transporter in both murine and human (49, 50) . Cell lines include the murine fibroblast NIH/3T3 line, NIH/3T3 cells transformed by stable transfection of either H-ras or Src, in Ras/3T3 or Src/3T3 cells, respectively (55), a primary human foreskin fibroblast line (cell designation CCD 1112Sk, from the American Type Culture Collection, Manassas, VA) and the human fibrosarcoma cell line HT1080.
Growth curves of the cell lines over a 4-day period are shown in Fig. 1 . After replating, the cells have a lag phase before assuming log phase growth from day 3. The largest differences were observed at day 4. The transformed Ras/3T3, Src/3T3, and HT1080, cell lines grew more rapidly than their nontransformed or primary culture counterparts.
Transport of agmatine significantly increases in transformed Ras/3T3 and Src/3T3 cells relative to the parental murine NIH/3T3 cell line (Fig. 2A) . Cellular uptake of agmatine also appreciably increases in human fibrosarcoma cells, HT1080, relative to the primary fibroblast cell line. We observe a significant increase in agmatine import from nontransformed to transformed variants of mammalian cell lines, regardless of whether the cells are of murine or human origin.
HPLC analysis shows an accumulation of intracellular agmatine levels that increase after incubation with 100 M agmatine for 16 h in transformed cell lines relative to the primary and immortalized lines in a pattern similar to that of agmatine transport (Fig. 2B) . The potential of agmatine within the cell depends not only on import, but also on export and metabolism. The equilibrium of these components is represented by the intracellular accumulation of agmatine. Baseline levels of agmatine in cells in culture are very low to undetectable, so we assume the effects observed are due to addition of exogenous agmatine.
Preferential suppression of growth by agmatine in transformed cells. Preferential uptake and accumulation of agmatine into transformed cell lines suggest that these cell lines would be more responsive to the antiproliferative effects of agmatine. We evaluated cell growth, as a function of accrued cell number after 4 days in the presence of agmatine relative to untreated control cells, the latter being set to 100% (Fig. 3) . All transformed cell lines demonstrated a significant decrease in cell number relative to their untreated controls by 50 M agmatine, immortalized NIH/3T3 cells by 250 M agmatine, and primary fibroblasts were not significantly affected by agmatine within this concentration range. The SV40 transformed the renal proximal tubule cell line, and MCT, displayed a similar sensitivity to agmatine as exhibited here by the transformed variants (42) .
Polyamine supplementation or inhibition of polyamine transport suppresses the effects of agmatine. We preloaded Ras/3T3 cells with the polyamine putrescine and evaluated the effects of agmatine on cell growth, as per Fig. 3 . Addition of putrescine to Ras/3T3 cells attenuated the antiproliferative effects of agmatine (Fig. 4A) . Competitive inhibition of agmatine uptake by putrescine would also contribute to this effect. Uptake rates of agmatine and putrescine are quite similar in these cells (40) . At equimolar concentrations of agmatine and putrescine, that is, at 250 M, would yield a 50% inhibition of agmatine uptake. The effects of putrescine administration are far greater than can be accounted for by competitive inhibition alone. These data support earlier work that the antiproliferative effects observed with agmatine are due in large part to polyamine depletion (42) .
We next evaluated the significance of the polyamine transport system on the antiproliferative effects of agmatine. Administration of the polyamine transport inhibitors MQT1202 and MQT1483 prevented the inhibitory effects of agmatine on Ras/3T3 cells (Fig. 4B) . Thus, polyamine transporters are required for significant import of agmatine into these cells to produce antiproliferative effects.
Effects of agmatine on induction of antizyme. Induction of antizyme occurs in many cell types in response to agmatine administration. Increased uptake of agmatine into the more rapidly proliferating transformed cells should affect antizyme induction, assuming that antizyme function and/or induction is not desensitized by transformation. NIH/3T3, Ras/3T3, and Src/3T3 cells were grown for 4 days in the absence or presence of agmatine (250 M and 500 M) and antizyme expression evaluated by Western blot analysis (Fig. 5A) . Antizyme expression consistently increased to a greater degree in the transformed cell lines in response to agmatine administration than the parental NIH/3T3 cell line. Putrescine (250 M), agmatine (1 mM), or a combination of the two-increased antizyme protein expression in Ras/3T3 cells (Fig. 5B) . Increases in antizyme in response to agmatine administration were confirmed in antizyme activity assays (not shown).
DISCUSSION
The differential uptake and accumulation of agmatine in transformed relative to nontransformed cell lines correlate with the antiproliferative effects of agmatine. Oncogene transformed murine cells, Ras/3T3 and Src/3T3, and human fibrosarcoma, HT1080, exhibit accelerated growth rates, higher agmatine uptake, and intracellular agmatine concentrations, and they are more sensitive to the antiproliferative effects of agmatine than are their respective immortalized, NIH/3T3, or primary fibroblast counterparts. Two breast carcinoma cell lines, N2O2 and PC7T, also displayed a high sensitivity to agmatine, similar to the fibrosarcoma cell line, HT1080. Akin to the canonical polyamines, agmatine is a cationic molecule with amine groups that are subject to acetylation. This process neutralizes the charge of the molecules and facilitates their cellular export. Unlike the simple amines of polyamines, the guanidino group of agmatine may allow for a different intracellular localization (2) and make it less prone to cellular export.
The kidney, liver, brain, and adrenals maintain high constitutive levels of ADC activity (20, 27) . Although ADC was localized to the mitochondrial membrane, agmatine generation was not observed in mitochondrial extracts (8) . This is contrary to findings in whole organ preparations (20) and requires further examination. Whether sourced from the gut flora or biosynthesis within organs, agmatine is widely distributed within the plasma (2.8 M; see Ref. 19 ) and extracellular fluid and can be selectively concentrated in several organs (19, 36) . Concentrations of agmatine in early reports were underestimated due to the lability of the molecule in the derivatization process, a problem that has not been entirely eradicated. More recently, the tissue level of agmatine in the rat kidney was reported to approximate over 400 M (19) . In all of the cell lines evaluated in this report, the growth rates of transformed cells treated with 50 M agmatine were significantly different from their untreated controls, with a maximal effect at ϳ500 M. Rat hepatoma cells, HTC, exhibit a similar profile in response to agmatine with a significance at 50 M and maximal effects at 500 M (personal communication, Sebastiano Colombatto, University of Torino, Italy).
Expression of antizyme is primarily controlled at the translational level through ribosomal frameshifting, although there is also a transcriptional mechanism when polyamines are depleted (30) . However, there has been no evidence that the polyamine dose response/frameshift kinetics are altered by malignant transformation. The polyamine concentrations required for maximal frameshift efficiency, and the degree of frameshift efficiency was the same in transformed MCT cells as reported for normal rat liver (23, 42) . Immunoprecipitation of antizyme from agmatine-treated MCT cell preparations prevented the inhibitory effects on ODC activity (42) . We show that agmatine significantly increases antizyme protein levels in two transformed cell lines and also that loading cells with putrescine reduces the effects of agmatine on proliferation. The antiproliferative effects of agmatine thus appear due to polyamine depletion and not due to agmatine functionally replacing or displacing the canonical polyamines (42) . Agmatine appears to require cellular import for its antiproliferative effects. It is a multifunctional molecule with both receptordependent and -independent functions. As import is required (Fig. 4B) , the antiproliferative effects evaluated in this study appear receptor independent. Furthermore, exogenously administered putrescine or agmatine imported into the cytosol induces antizyme expression (Fig. 5B) . These studies are in accord with studies demonstrating temporal translocation and compartmentalization of ODC and antizyme (11, 34, 47) . Taken together, these data would suggest a mechanism whereby the rapid conversion and utilization of polyamines may result in lower unbound or "free" cytosolic polyamine levels that are insufficient to induce antizyme expression, and/or how the inhibitor may be unable to reach the enzyme, depending upon the physiological status of the cell. However, this hypothesis cannot be directly substantiated by current techniques. We do show that exogenously administered putrescine or agmatine, which imports into the cytosol, is capable of inducing antizyme expression.
Agmatine would be complementary, that is, additive, to the endogenous polyamine pool and thereby effectively lower the threshold levels of polyamines required to bring about the translational induction of antizyme. In addition, induction of antizyme by agmatine could constitute a self-limiting feedback mechanism by inhibiting both polyamine and agmatine uptake (Fig. 6 ). Taken together, these observations suggest that the polyamine feedback system in these transformed cells is functional, but it may be evaded in proliferating cells. This is not to say that regulation of antizyme expression is not altered in some neoplasms (18, 46) but suggests that such alteration is not as universal in neoplasia as is increased ODC activity. Several studies support the view that induction of antizyme may prove to be a viable method of attenuating neoplastic growth (10, 16, 18, 32) .
In summary, the preferential antiproliferative effects of agmatine on several transformed mammalian cell lines occurs from enhanced cellular uptake by polyamine transporters, and subsequent suppression of proliferation. This process exploits the upregulation of polyamine transporters in rapidly cycling cells and may be a useful template for drug development. Fig. 6 . Proposed mechanism. Rapidly dividing cells upregulate polyamine transport. Intracellular agmatine accumulation by synthesis and/or transport mediates antizyme induction. Antizyme suppresses intracellular polyamine levels by inhibiting polyamine synthesis and transport and limits further agmatine uptake through the polyamine transporter. Agmatine may also induce spermidine/spermine acetyltransferase activity and reduce ornithine decarboxylase (ODC) activity independent of antizyme (not illustrated). These mechanisms would also reduce intracellular polyamine content. Bars represent negative regulation; ovals in cell membrane symbolize polyamine transporters. ADC. arginine decarboxylase. 
